SEC Form 4 · accession 0001127602-16-054604
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha Goldberg Aronson
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 3, 2016 · 11:22 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF1 | $41.06 | Jun 1, 2016 | A | 5,396 | A | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 5,396 | 5,396 | D |
| Rsus (restricted Stock Units)F2 | $0.00 | Jun 1, 2016 | A | 2,739 | A | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 2,739 | 2,739 | D |
Explanation of responses
- F1The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.